Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 21, Issue 3, 2010, Pages 939-945

  Jang, Bong Geom ^a   Yun, Sang Moon ^a   Ahn, Kyungsook ^a   Song, Ju Hee ^a   Jo, Sangmee A ^a   Kim, Young Yul ^a   Kim, Doh Kwan ^b   Park, Moon Ho ^c   Han, Changsu ^c   Koh, Young Ho ^a  

^a Korea National Institute of Health   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; carbonic anhydrase II; mild cognitive impairment; plasma

Indexed keywords

CARBONATE DEHYDRATASE II;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 77957272701     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100384     Document Type: Article

References (26)

1. Wen Z, Xie J, Guan Z, Sun D, Yao W, Chen K, Yan ZY, Mu Q (2000) A study of hemorheological behaviour for patients with Alzheimer's disease at the early stages. Clin Hemorheol Microcirc 22, 261266.
2. Knopman DS, DeKosky ST, Cummings JL, Chui H, CoreyBloom J, Relkin N, Small GW, Miller B, Stevens JC (2001) Practice parameter: Diagnosis of dementia (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 11431153. (Pubitemid 32405708)
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, BarbergerGateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'Brien J, Pasquier F, Robert P, RossorM, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDSADRDA criteria. Lancet Neurol 6, 734746. (Pubitemid 47058377)
4. Blennow K, De Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387403. (Pubitemid 44108123)
5. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA (2006) Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22, 7687.
6. Kawarabayashi T, Shoji M (2008) Plasma biomarkers of Alzheimer's disease. Curr Opin Psychiatry 21, 260267. (Pubitemid 351489346)
7. Sun MK, Alkon DL (2002) Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 23, 8389.
8. Maren TH (1988) The kinetics of HCO3synthesis related to fluid secretion, pH control, and CO2 elimination. Annu Rev Physiol 50, 695717.
9. Sultana R, BoydKimball D, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA (2007) Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 11, 153164. (Pubitemid 47010980)
10. Sly WS, HewettEmmett D, Whyte MP, Yu YS, Tashian RE (1983) Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A 80, 27522756.
11. SlyWS,WhyteMP, SundaramV, Tashian RE,HewettEmmett D, Guibaud P, Vainsel M, Baluarte HJ, Gruskin A, AlMosawi M, et al. (1985)Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313, 139145. (Pubitemid 15047455)
12. Wu CC, Peng PH, Chang YT, Huang YS, Chang KP, Hao SP, Tsang NM, Yeh CT, Chang YS, Yu JS (2008) Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cydye labeling combined with threedimensional fractionation. Proteomics 8, 36053620.
13. Jo SA, Ahn K, Kim E, Kim HS, Jo I, Kim DK, Han C, Park MH (2008) Association of BACE1 gene polymorphism with Alzheimer's disease in Asian populations: metaanalysis including Korean samples. Dement Geriatr Cogn Disord 25, 165169. (Pubitemid 351196129)
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM(1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices ofDepartment ofHealth andHuman Services Task Force on Alzheimer's Disease. Neurology 34, 939944. (Pubitemid 14076461)
15. Han C, Jo SA, Seo JA, Kim BG, Kim NH, Jo I, Park MH, Park KW (2009) Adiposity parameters and cognitive function in the elderly: Application of "Jolly Fat" hypothesis to cognition. Arch Gerontol Geriatr 49, e133e138.
16. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303308. (Pubitemid 29120227)
17. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI (2002) Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's DiseaseAssessment Packet (CERADK): Clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 57, P4753.
18. Petersen RC (2004)Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183194. (Pubitemid 39222988)
19. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 24122414.
20. MeierRuge W, Iwangoff P, Reichlmeier K, Sandoz P (1980) Neurochemical findings in the aging brain. Adv Biochem Psychopharmacol 23, 323338.
21. Palminiello S, Kida E, Kaur K, Walus M, Wisniewski KE, WierzbaBobrowicz T, Rabe A, Albertini G, Golabek AA (2008) Increased levels of carbonic anhydrase II in the developing Down syndrome brain. Brain Res 1190, 193205.
22. Parkkila AK, Parkkila S, Reunanen M, Niemela O, Tuisku S, Rautakorpi I, Rajaniemi H (1997) Carbonic anhydrase II in the cerebrospinal fluid: Its value as a disease marker. Eur J Clin Invest 27, 392397. (Pubitemid 27242510)
23. Conrad CC, Marshall PL, Talent JM, Malakowsky CA, Choi J, Gracy RW(2000) Oxidized proteins in Alzheimer's plasma. Biochem Biophys Res Commun 275, 678681.
24. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW (2002) Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293, 15661570. (Pubitemid 34681057)
25. Sultana R, BoydKimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA (2006) Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27, 15641576. (Pubitemid 44344840)
26. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 4752.